Showing 301 - 320 results of 123,395 for search '(( 6 1 decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.83s Refine Results
  1. 301
  2. 302

    Unusual [3+1] Cycloaddition of a Stable Silylene with a 2,3-Diazabuta-1,3-diene versus [4+1] Cycloaddition toward a Buta-1,3-diene by Yun Xiong (1403545)

    Published 2010
    “…Cycloaddition reactions of the thermally stable N-heterocyclic silylene LSi: <b>1</b> {L = CH[(CCH<sub>2</sub>)CMe][N(Ar)]<sub>2</sub>], Ar = 2,6-<i>i</i>Pr<sub>2</sub>C<sub>6</sub>H<sub>3</sub>} with acetone azine (1,1,4,4-tetramethyl-2,3-diazabuta-1,3-diene) and buta-1,3-diene derivatives have been probed. …”
  3. 303

    Roscovitine decreases transcription of fibrogenic mediators. by Richard A. Steinman (117481)

    Published 2012
    “…RNA from confluent primary fibroblasts incubated for 36 hours with DMSO vehicle (1), 6.25 µg/mL roscovitine (2), or 12.5 µg/mL roscovitine (3) was blotted and probed for <i>CTGF</i>, collagen, and fibronectin mRNA. …”
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314
  15. 315
  16. 316

    Panel (a) compares SO<sub>2</sub> emissions prescribed over the historical period in the CMIP5 simulations (solid grey) with three inventory-based estimates of historical emissions... by Nathan P Gillett (557010)

    Published 2013
    “…SO<sub>2</sub> emissions over the 21st century specified in the RCP 2.6, 4.5 and 8.5 scenarios [<a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib8" target="_blank">8</a>] (solid coloured lines) are compared with those specified in the SRES A1, A2, B1 and B2 scenarios [<a href="http://iopscience.iop.org/1748-9326/8/3/034008/article#erl467068bib9" target="_blank">9</a>] (dashed coloured lines). …”
  17. 317
  18. 318
  19. 319

    <i>MTHFR</i>677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial by Leopold K. Fezeu (5309333)

    Published 2018
    “…</p><p>Methods</p><p>2381 patients with a personal history of cardiovascular disease were randomly assigned to one of four groups: 1) B-vitamins alone (560 μg of 5-methyl-THF, 3 mg of vitamin B<sub>6</sub> and 20 μg of vitamin B<sub>12</sub>), 2) n-3 fatty acids alone (600 mg of EPA and DHA in a 2:1 ratio), 3) B-vitamins and n-3 fatty acids, and 4) placebo. …”
  20. 320